These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 32134204

  • 1. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
    Bhandari R, Ball MS, Martyanov V, Popovich D, Schaafsma E, Han S, ElTanbouly M, Orzechowski NM, Carns M, Arroyo E, Aren K, Hinchcliff M, Whitfield ML, Pioli PA.
    Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
    [Abstract] [Full Text] [Related]

  • 2. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
    Bujor AM, El Adili F, Parvez A, Marden G, Trojanowska M.
    Front Immunol; 2020 Jul; 11():800. PubMed ID: 32508810
    [Abstract] [Full Text] [Related]

  • 3. Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis.
    Rudnik M, Hukara A, Kocherova I, Jordan S, Schniering J, Milleret V, Ehrbar M, Klingel K, Feghali-Bostwick C, Distler O, Błyszczuk P, Kania G.
    Front Immunol; 2021 Jul; 12():642891. PubMed ID: 34504485
    [Abstract] [Full Text] [Related]

  • 4. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE.
    Arthritis Res Ther; 2013 Oct 28; 15(5):R168. PubMed ID: 24289101
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
    Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.
    PLoS One; 2016 Oct 28; 11(11):e0166433. PubMed ID: 27846260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
    Wu M, Pedroza M, Lafyatis R, George AT, Mayes MD, Assassi S, Tan FK, Brenner MB, Agarwal SK.
    Arthritis Rheumatol; 2014 Apr 28; 66(4):1010-21. PubMed ID: 24757152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.
    Yamamoto T, Eckes B, Hartmann K, Krieg T.
    J Dermatol Sci; 2001 Jun 28; 26(2):133-9. PubMed ID: 11378330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS, Reed TJ, Berthier CC, Tsou PS, Liu J, Gudjonsson JE, Khanna D, Kahlenberg JM.
    Rheumatology (Oxford); 2017 Nov 01; 56(11):1970-1981. PubMed ID: 28968684
    [Abstract] [Full Text] [Related]

  • 16. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
    Wei J, Ghosh AK, Chu H, Fang F, Hinchcliff ME, Wang J, Marangoni RG, Varga J.
    Arthritis Rheumatol; 2015 May 01; 67(5):1323-34. PubMed ID: 25707573
    [Abstract] [Full Text] [Related]

  • 17. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT, Ong VH, Ponticos M, Shiwen X, Abraham DJ, Black CM, Denton CP.
    Arthritis Rheum; 2005 Dec 01; 52(12):3772-82. PubMed ID: 16320328
    [Abstract] [Full Text] [Related]

  • 18. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
    Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, Yonemura Y, Komohara Y, Takeya M, Mitsuya H, Ihn H.
    Arthritis Res Ther; 2010 Dec 01; 12(4):R128. PubMed ID: 20602758
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C, Ramming A, Bergmann C, Weinkam R, Kittan N, Schett G, Distler JHW, Beyer C.
    Ann Rheum Dis; 2017 Jun 01; 76(6):1133-1141. PubMed ID: 28209630
    [Abstract] [Full Text] [Related]

  • 20. CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis.
    van der Kroef M, Carvalheiro T, Rossato M, de Wit F, Cossu M, Chouri E, Wichers CGK, Bekker CPJ, Beretta L, Vazirpanah N, Trombetta E, Radstake TRDJ, Angiolilli C.
    J Autoimmun; 2020 Jul 01; 111():102444. PubMed ID: 32284212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.